Community pharmacists' preparedness for substituting biologics and dispensing biosimilars: Lessons learned from a multinational survey
Research output: Contribution to journal › Journal article › Research › peer-review
Documents
- Fulltext
Final published version, 272 KB, PDF document
Interchangeability between biological medicines and biosimilars, and subsequent substitution by pharmacists represent an important opportunity for costs savings for health care systems. Because biological medicines are complex products, the expert role of the pharmacist to inform patients and support physicians is indispensable. However, regulations on substitution of biosimilars differ around the globe, such that a substitution that is allowed in one country may be forbidden in another. Overall, pharmacists' knowledge of biosimilar medicines is incomplete and hesitancy to engage in substitutions is perceptible. As counter-balancing remedy, continued education about biosimilars is needed among practicing community pharmacists.
Original language | English |
---|---|
Article number | 100084 |
Journal | Exploratory Research in Clinical and Social Pharmacy |
Volume | 4 |
Number of pages | 4 |
DOIs | |
Publication status | Published - 2021 |
ID: 300448919